Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0001209191-23-050259

EVP and CMO sold 5,651 shares at $351.00 ($1,983,501)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Bozic Carmen · EVP and CMO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-09-19 Sale : show line 1 in the form 10b5-1 −5,651 $351.00 $1,983,501 51,905 D
Open-market sales · 5,651 sh · avg $351.00 · $1,983,501
Loading xslF345X05/doc4.xml…